admin.bio

24
Feb

Biofortuna Ltd appoints new Chairman to lead next phase of growth

UK based molecular diagnostics company Biofortuna has appointed a new Chairman to lead the next phase of growth. Life sciences expert Ian Johnson will take on the role at Biofortuna with previous Chairman Mark Hurley remaining on the board as a Non-executive Director. Biofortuna, based in the Wirral, specialises in proprietary freeze-dried diagnostics and contract services. It recently announced a

Read more

29
Jan

Biofortuna Ltd closes a £1.5m funding round

Biofortuna Ltd, the UK based molecular diagnostics company specialising in its proprietary freeze-dried diagnostics and contract services, announces raising £1.5m in its latest funding round. The £1.5m funding was supported by all the company’s current investors; Foresight VCTs, Catapult Ventures, Enterprise Ventures, MSIF, private investors and management. The new funding is for Biofortuna to develop a portfolio of new molecular

Read more